Celestica (CLS) EBITDA (2024 - 2026)

Celestica (CLS) has reported EBITDA for 3 consecutive years, with $458.3 million the latest figure, recorded in Q2 2026.

• On a quarterly basis, EBITDA rose 68.18% year-over-year to $458.3 million in Q2 2026; TTM through Jun 2026 was $1.4 billion, a 84.63% increase from a year earlier, with the FY2025 full-year figure at $1.0 billion, up 73.65% from the prior year.
• EBITDA was $458.3 million for Q2 2026 at Celestica, up from $272.1 million in the prior quarter.
• Over five years, EBITDA peaked at $458.3 million in Q2 2026 and troughed at $125.8 million in Q1 2024.
• A 3-year average of $237.0 million and a median of $237.4 million in 2024 frame the typical range for EBITDA.
• The widest YoY moves for EBITDA: up 135.51% in 2025, down 2.38% in 2025.
• Over 3 years, EBITDA stood at $202.6 million in 2024, then jumped by 55.18% to $314.4 million in 2025, then surged by 45.77% to $458.3 million in 2026.
• The last three EBITDA figures came in at $458.3 million (Q2 2026), $272.1 million (Q1 2026), and $314.4 million (Q4 2025), per Business Quant data.